Payment overview · 2025
General Payments
$174.90
2 reported records · 2 companies
Healthcare provider profile · identity verified
Shirley Ramos
Allopathic & Osteopathic Physicians|Family Medicine · LARES, PR · NPI 1013204981
Verified facts
What the public records show
CMS Open Payments records show Shirley Ramos received $174.90 in general payments during 2025 across 2 reported records.
ABBVIE INC. accounted for 68.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 369 claims for Synthroid by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $120.16 | 68.7% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $54.74 | 31.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $174.90 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $120.16 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Lilly USA, LLC | $54.74 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
369 | 73 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Famotidine | Famotidine | 892 | 164 |
| Gabapentin | Gabapentin | 787 | 155 |
| Atorvastatin Calcium | Atorvastatin Calcium | 693 | 160 |
| Pantoprazole Sodium | Pantoprazole Sodium | 642 | 130 |
| Simvastatin | Simvastatin | 535 | 107 |
| Losartan Potassium | Losartan Potassium | 462 | 95 |
| Metformin Hcl | Metformin Hcl | 458 | 94 |
| Clonazepam | Clonazepam | 439 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 377 | 74 |
| Montelukast Sodium | Montelukast Sodium | 373 | 90 |
| Synthroid | Levothyroxine Sodium | 369 | 73 |
| Amlodipine Besylate | Amlodipine Besylate | 341 | 83 |
| Lisinopril | Lisinopril | 339 | 66 |
| Omeprazole | Omeprazole | 301 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 289 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 271 | 80 |
| Tamsulosin Hcl | Tamsulosin Hcl | 249 | 54 |
| Glimepiride | Glimepiride | 204 | 47 |
| Tizanidine Hcl | Tizanidine Hcl | 199 | 92 |
| Fluticasone Propionate | Fluticasone Propionate | 198 | 88 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 194 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 173 | 35 |
| Baclofen | Baclofen | 171 | 44 |
| Alendronate Sodium | Alendronate Sodium | 168 | 35 |
| Donepezil Hcl | Donepezil Hcl | 161 | 25 |
| Temazepam | Temazepam | 154 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 150 | 43 |
| Lorazepam | Lorazepam | 148 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 147 | 22 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 145 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 140 | 71 |
| Atenolol | Atenolol | 134 | 26 |
| Methylprednisolone | Methylprednisolone | 134 | 117 |
| Sertraline Hcl | Sertraline Hcl | 124 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 123 | 21 |
| Finasteride | Finasteride | 120 | 28 |
| Irbesartan | Irbesartan | 120 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 119 | 34 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 115 | 33 |
| Meloxicam | Meloxicam | 110 | 71 |
| Diclofenac Potassium | Diclofenac Potassium | 107 | 58 |
| Enalapril Maleate | Enalapril Maleate | 103 | 19 |
| Trazodone Hcl | Trazodone Hcl | 98 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 96 | 22 |
| Carvedilol | Carvedilol | 92 | 21 |
| Candesartan Cilexetil | Candesartan Cilexetil | 91 | 17 |
| Ketoconazole | Ketoconazole | 89 | 44 |
| Latanoprost | Latanoprost | 89 | 14 |
| Nabumetone | Nabumetone | 89 | 28 |
| Alprazolam | Alprazolam | 88 | suppressed |
| Memantine Hcl | Memantine Hcl | 88 | 19 |
| Furosemide | Furosemide | 83 | 37 |
| Ibandronate Sodium | Ibandronate Sodium | 83 | 19 |
| Buspirone Hcl | Buspirone Hcl | 82 | 16 |
| Levofloxacin | Levofloxacin | 79 | 68 |
| Farxiga | Dapagliflozin Propanediol | 76 | 17 |
| Pregabalin | Pregabalin | 76 | 13 |
| Glipizide | Glipizide | 74 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 72 | 14 |
| Dexamethasone | Dexamethasone | 70 | 64 |
| Diclofenac Sodium Er | Diclofenac Sodium | 70 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 70 | 18 |
| Azithromycin | Azithromycin | 69 | 63 |
| Amitriptyline Hcl | Amitriptyline Hcl | 68 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 65 | 12 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 64 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 63 | 27 |
| Spironolactone | Spironolactone | 63 | 15 |
| Sulindac | Sulindac | 62 | 33 |
| Cilostazol | Cilostazol | 60 | 14 |
| Xarelto | Rivaroxaban | 60 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 58 | suppressed |
| Risperidone | Risperidone | 57 | suppressed |
| Eliquis | Apixaban | 53 | 13 |
| Glipizide Er | Glipizide | 52 | 12 |
| Levetiracetam | Levetiracetam | 52 | 11 |
| Mirtazapine | Mirtazapine | 52 | 15 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 49 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 47 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 47 | suppressed |
| Chlorthalidone | Chlorthalidone | 46 | suppressed |
| Topiramate | Topiramate | 46 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | 42 |
| Estazolam | Estazolam | 44 | suppressed |
| Ezetimibe | Ezetimibe | 44 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 42 | suppressed |
| Prednisone | Prednisone | 42 | 27 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 42 | 12 |
| Trueplus Insulin Syringe | Syringe And Needle,insulin,1ml | 41 | suppressed |
| Fluconazole | Fluconazole | 40 | 35 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 39 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 39 | 13 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 39 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 38 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 37 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 37 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 35 | 15 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 35 | suppressed |
| Sucralfate | Sucralfate | 35 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 34 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 34 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 33 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 32 | 26 |
| Memantine Hcl Er | Memantine Hcl | 32 | suppressed |
| Naproxen | Naproxen | 32 | 15 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 28 |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Levoxyl | Levothyroxine Sodium | 30 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Colchicine | Colchicine | 25 | 11 |
| Permethrin | Permethrin | 25 | 21 |
| Allopurinol | Allopurinol | 24 | 11 |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 21 |
| Betamethasone Valerate | Betamethasone Valerate | 23 | 13 |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | 18 |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 13 |
| Jentadueto | Linagliptin/Metformin Hcl | 20 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 19 | 16 |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 19 | suppressed |
| Ivermectin | Ivermectin | 19 | 19 |
| Rivastigmine | Rivastigmine | 19 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 19 | 12 |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 19 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 18 | suppressed |
| Etodolac Er | Etodolac | 18 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Pentoxifylline | Pentoxifylline | 18 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 18 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 17 | suppressed |
| Glipizide Xl | Glipizide | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Ciclopirox | Ciclopirox | 16 | 13 |
| Humalog | Insulin Lispro | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Chlordiazepoxide-Clidinium | Chlordiazepoxide/Clidinium Br | 15 | suppressed |
| Haloperidol | Haloperidol | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Procto-Med Hc | Hydrocortisone | 15 | 11 |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 12 |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 14 | suppressed |
| Acetic Acid | Acetic Acid | 13 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | 11 |
| Lacosamide | Lacosamide | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 11 | suppressed |
| Jardiance | Empagliflozin | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Mesalamine Dr | Mesalamine | 11 | suppressed |
| Perphenazine | Perphenazine | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $174.90 · 2 records | ABBVIE INC. | JARDIANCE, UBRELVY | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error